New asthma drug APG777 enters early human testing
NCT ID NCT06920901
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 21 times
Summary
This study tests a new drug called APG777 in 31 adults with mild-to-moderate asthma. The main goal is to check if the drug is safe and how the body processes it. Participants receive either the drug or a placebo, and researchers monitor for side effects and measure drug levels in the blood over about a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site
La Jolla, California, 92037, United States
-
Investigational Site
Long Beach, California, 90808, United States
-
Investigational Site
San Jose, California, 95117, United States
-
Investigational Site
Torrance, California, 90505, United States
-
Investigational Site
Normal, Illinois, 61761, United States
-
Investigational Site
Kansas City, Missouri, 66160, United States
-
Investigational Site
Edmond, Oklahoma, 73034, United States
-
Investigational Site
Philadelphia, Pennsylvania, 19140, United States
-
Investigational Site
Pittsburgh, Pennsylvania, 15241, United States
-
Investigational Site
Bradford, West Yorkshire, BD9 6RJ, United Kingdom
-
Investigational Site
Manchester, M23 9QZ, United Kingdom
Conditions
Explore the condition pages connected to this study.